For instance, Sorafenib targeting v-Raf murine sarcoma viral oncogene homolog B (B-Raf) kinase triggers re-expression of TTP in melanoma cells via the inhibition of B-Raf-dependent ERK activity [95]. Here, ZFP36 is linked to melanoma.